We derived a mouse model in which a mutant form of Nbs1 (Nbs1 mid8 ) exhibits severely impaired binding to the Mre11-Rad50 core of the Mre11 complex. The Nbs1 mid8 allele was expressed exclusively in hematopoietic lineages (in Nbs1 -/mid8vav mice). Unlike Nbs1 flox/floxvav mice, which are Nbs1 deficient in the bone marrow, Nbs1 -/mid8vav mice were viable. Nbs1 -/mid8vav hematopoiesis was profoundly defective, exhibiting reduced cellularity of thymus and bone marrow, and stage specific blockage of B cell development. Within six months, Nbs1 -/mid8 mice developed highly penetrant T cell leukemias. Nbs1 -/mid8vav leukemias recapitulated mutational features of human T-ALL, containing mutations in Notch1, Trp53, Bcl6, Bcor, and Ikzf1, suggesting that Nbs1 mid8 mice may provide a venue to examine the relationship between the Mre11 complex and oncogene activation in the hematopoietic compartment. Genomic analysis of Nbs1 -/mid8vav malignancies showed focal amplification of 9qA2, causing overexpression of MRE11 and CHK1. We propose that overexpression compensates for the meta-stable Mre11-Nbs1 mid8 interaction, and that selection pressure for overexpression reflects the essential role of Nbs1 in promoting assembly and activity of the Mre11 complex.Ddx3x